Global Next Generation Sequencing Market 2015-2019 with Illumina, Roche Diagnostics & Thermo Fischer Scientific Dominating


Dublin, May 20, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/q97wfn/global_next) has announced the addition of the "Global Next Generation Sequencing Market 2015-2019" report to their offering.

The global next generation sequencing market to grow at a CAGR of 21.36% over the period 2014-2019

This report covers the present scenario and the growth prospects of the global next generation sequencing market for the period 2015-2019. The global next generation sequencing market is divided into two segments: equipment, and reagents and consumables.

One of the major trend in this market is strategic alliances between large corporations and specialized companies for enhancing their business in genomic sequencing. For instance, in 2014 Thermo Fisher Scientific collaborated with Pfizer and GSK to develop oncology companion diagnostics using NGS technology. These alliances enhance the expertise in DNA sequencing and accelerate drug discovery efforts.

According to the report, one of the major factors expected to drive the market is advances in applications of NGS in molecular biology and biomedical engineering. The evolution of NGS technology as a molecular microscope has created interest among researchers, hospitals, and pharmaceutical and life sciences companies in finding solutions for complex biological questions.

Further, the report states that one of the challenge is the lack of standardization in data analysis.

To calculate the market size, the report considers the revenue generated from the sales of equipment, and reagents and consumables used in next generation sequencing in the following customer segments:

  • Commercial entities such as hospitals and pharmaceutical and life sciences companies
  • Research institutes

Key Vendors

  • Illumina
  • Roche Diagnostics
  • Thermo Fischer Scientific

Other Prominent Vendors

  • 10X Genomics
  • 23andMe
  • Ambry Genetics
  • Axeq Technologies
  • Beijing Genomics Institute
  • CLC bio
  • Clontech Laboratories
  • Fluidigm
  • Foundation Medicine
  • GATC Biotech
  • GeneDx
  • GENEWIZ
  • Gnomegen
  • Good Start Genetics
  • Ingenuity Systems
  • Knome
  • NABsys
  • Oxford Nanopore Technologies
  • Pathogenica
  • PerkinElmer
  • RainDance Technologies
  • Rubicon Genomics
  • Sequenom
  • Sigma-Aldrich
  • Source Biosciences
  • Takara Bio

For more information visit http://www.researchandmarkets.com/research/q97wfn/global_next




            

Contact Data